FAIR in action - a flexible framework to guide FAIRification
The COVID-19 pandemic has highlighted the need for FAIR (Findable, Accessible, Interoperable, and Reusable) data more than any other scientific challenge to date. We developed a flexible, multi-level, domain-agnostic FAIRification framework, providing practical guidance to improve the FAIRness for b...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2023
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
LEADER | 02342nam a2200493Ia 4500 | ||
---|---|---|---|
001 | 10.1038-s41597-023-02167-2 | ||
008 | 230529s2023 CNT 000 0 und d | ||
020 | |a 20524463 (ISSN) | ||
245 | 1 | 0 | |a FAIR in action - a flexible framework to guide FAIRification |
260 | 0 | |b NLM (Medline) |c 2023 | |
856 | |z View Fulltext in Publisher |u https://doi.org/10.1038/s41597-023-02167-2 | ||
856 | |z View in Scopus |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159717611&doi=10.1038%2fs41597-023-02167-2&partnerID=40&md5=415e23b06cc1ee720ad4f8ba1230dfa7 | ||
520 | 3 | |a The COVID-19 pandemic has highlighted the need for FAIR (Findable, Accessible, Interoperable, and Reusable) data more than any other scientific challenge to date. We developed a flexible, multi-level, domain-agnostic FAIRification framework, providing practical guidance to improve the FAIRness for both existing and future clinical and molecular datasets. We validated the framework in collaboration with several major public-private partnership projects, demonstrating and delivering improvements across all aspects of FAIR and across a variety of datasets and their contexts. We therefore managed to establish the reproducibility and far-reaching applicability of our approach to FAIRification tasks. © 2023. The Author(s). | |
650 | 0 | 4 | |a Agnostic |
650 | 0 | 4 | |a article |
650 | 0 | 4 | |a FAIR principles |
650 | 0 | 4 | |a fairness |
650 | 0 | 4 | |a human |
650 | 0 | 4 | |a public-private partnership |
650 | 0 | 4 | |a reproducibility |
700 | 1 | 0 | |a Abbassi-Daloii, T. |e author |
700 | 1 | 0 | |a Alharbi, E. |e author |
700 | 1 | 0 | |a Boiten, J.-W. |e author |
700 | 1 | 0 | |a Burdett, T. |e author |
700 | 1 | 0 | |a Courtot, M. |e author |
700 | 1 | 0 | |a Emam, I. |e author |
700 | 1 | 0 | |a Gadiya, Y. |e author |
700 | 1 | 0 | |a Giessmann, R.T. |e author |
700 | 1 | 0 | |a Goble, C. |e author |
700 | 1 | 0 | |a Gray, A.J.G. |e author |
700 | 1 | 0 | |a Gribbon, P. |e author |
700 | 1 | 0 | |a Gu, W. |e author |
700 | 1 | 0 | |a Henderson, D. |e author |
700 | 1 | 0 | |a Ioannidis, V. |e author |
700 | 1 | 0 | |a Juty, N. |e author |
700 | 1 | 0 | |a Lynch, N. |e author |
700 | 1 | 0 | |a Reilly, D.S. |e author |
700 | 1 | 0 | |a Rocca-Serra, P. |e author |
700 | 1 | 0 | |a Sansone, S.-A. |e author |
700 | 1 | 0 | |a Satagopam, V. |e author |
700 | 1 | 0 | |a Strubel, J. |e author |
700 | 1 | 0 | |a Welter, D. |e author |
700 | 1 | 0 | |a Xu, F. |e author |
773 | |t Scientific data |